Norleual-AngIV was used to inhibit HGF binding to the c-Met receptor, consequently blocking HGF-dependent signaling pathways involved in proliferation, invasion, and scattering
BPC-157 is a pentadecapeptide derived from a gastric protein fragment, while TB-500 is a synthetic analog of thymosin beta-4 associated with actin-binding dynamics and peptide-mediated cellular processes
[1][2] Cardiac, corneal, dermal, hair follicle, broader cell-migration models T4 / TB-500 has the heavier body of work
Anyone above the age of 18 and willing to increase their complexion, can take this treatment
doi: 10.1128/IAI.01062-06 121 MaciverI.LatimerJ
Use is restricted to trained professionals operating in laboratory or research settings, following appropriate safety and handling protocols.